TITLE

Tetrabenazine for Huntington's chorea

AUTHOR(S)
Soutar, C. A.
PUB. DATE
October 1970
SOURCE
British Medical Journal;10/3/1970, Vol. 4 Issue 5726, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098202

 

Related Articles

  • Tetrabenazine Tablets (Xenazine├é┬«). Elliot, William T.; Chan, James // Internal Medicine Alert;10/15/2008, Vol. 30 Issue 19, p149 

    The article offers information concerning the aspect of tetrabenazine tablet, which was marketed by Prestwick Pharmaceuticals Inc. as xenazine. It notes that the U.S. Food and Drug Administration has approved the tetrabenazine for the treatment of chorea associated with Huntington's disease....

  • Tetrabenazine. Hayden, Michael R.; Leavitt, Blair R.; Yasothan, Uma; Kirkpatrick, Peter // Nature Reviews Drug Discovery;Jan2009, Vol. 8 Issue 1, p17 

    In August 2008, tetrabenazine (Xenazine; Ovation Pharmaceuticals/Biovail) was approved by the US FDA for the treatment of chorea associated with Huntington's disease. This makes it the first treatment to be approved in the US for a symptom of this neurodegenerative disorder.

  • Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Frank, Samuel // BMC Neurology;2011, Vol. 11 Issue 1, p18 

    A correction to the article "Tetrabenazine As Anti-Chorea Therapy in Huntington Disease: An Open-Label Continuation Study," by Samuel Frank and colleagues that was published in a previous issue is presented.

  • New molecular entity.  // Formulary;Oct2008, Vol. 43 Issue 10, p354 

    The article discusses Xenazine, a tetrabenazine drug from Biovail and Ovation. According to that author, tetrabenazine is approved by the Food and Drug Administration for treating chorea, a disease associated with Huntington's disease. A controlled study was used to test the efficacy of the said...

  • Xenazine Gains First U.S. OK for Huntington's.  // Bioworld Week;8/25/2008, Vol. 16 Issue 34, p2 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) to Prestwick Pharmaceutical Inc.'s Xenazine (tetrabenazine) as a treatment for chorea. Accordingly, Prestwick's product is the first drug approved by FDA for chorea, which is a symptom of Huntington's disease....

  • New AAN Guideline for Treating Chorea in Huntington's Disease.  // Neurology Reviews;Aug2012, Vol. 20 Issue 8, p22 

    The article presents information on study according to which clinicians should prescribe as tetrabenazine 100 mg of per day, amantadine 300 and 400 mg per day, riluzole 200 mg per day for treatment of patient with Huntington's disease chorea.

  • News from the FDA.  // Patient Care;Nov2004, Vol. 38 Issue 11, p13 

    Presents news briefs concerning the U.S. Food and Drug Administration as of November 2004. Approval of the drug Sensipar for the treatment of secondary hyperparathyroidism and hypercalcemia; Fast-track designation assigned to Tetrabenazine, an investigational therapy for the treatment of chorea...

  • Prestwick's Xenazine Gains First U.S. OK for Huntington's. Young, Donna // BioWorld Today;8/18/2008, Vol. 19 Issue 160, p1 

    This article reports on the 2008 approval by the U.S. Food and Drug Administration (FDA) of Xenazine (tetrabenazine) as a treatment to control involuntary jerky movements, known as chorea, associated with Huntington's disease. Xenazine, a product of Prestwick Pharmaceutical Inc., has been shown...

  • New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine. Hussar, Daniel A. // Journal of the American Pharmacists Association: JAPhA;Nov/Dec2008, Vol. 48 Issue 6, p815 

    The article provides information on clevidipine butyrate, difluprednate and tetrabenazine. Clevidipine butyrate, an antihypertensive agent, is administered intravenously and indicated for reducing blood pressure when oral therapy is not feasible or not desirable. The treatment of inflammation...

  • DRUG APPROVED FOR HUNTINGTON'S DISEASE. MULLETT, STEVE // RN;Oct2008, Vol. 71 Issue 10, p23 

    The article reports that tetrabenazine has been approved by the U.S. Food and Drug Administration as the first-ever treatment for Huntington's disease. The drug was originally developed in the 1950s to treat symptoms of psychosis, but has been found to be safe and effective in treating chorea,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics